Showing 1 - 9 results of 9 for search 'Ching-Chuan Kuo', query time: 0.04s Refine Results
  1. 1
    Novel microtubule inhibitor MPT0B098 inhibits hypoxia-induced epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma

    Novel microtubule inhibitor MPT0B098 inhibits hypoxia-induced epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma by I-Ting Tsai, Ching-Chuan Kuo, Jing-Ping Liou, Jang-Yang Chang

    Published 2018-03-01
    Get full text
    Article
  2. 2
    A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway.

    A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway. by Nai-Jung Chiang, Ching-I Lin, Jing-Ping Liou, Ching-Chuan Kuo, Chi-Yen Chang, Li-Tzong Chen, Jang-Yang Chang

    Published 2013-01-01
    Get full text
    Article
  3. 3
    Synthesis and Biological Evaluation of 4-Aroyl-6,7,8-Trimethoxyquinolines as a Novel Class of Anticancer Agents

    Synthesis and Biological Evaluation of 4-Aroyl-6,7,8-Trimethoxyquinolines as a Novel Class of Anticancer Agents by Jing-Ping Liou, Jang-Yang Chang, Chih-Ying Nien, Cheng-Chih Hsieh, Chi-Yen Chang, Ching-Chuan Kuo, Hsueh-Yun Lee

    Published 2011-03-01
    Get full text
    Article
  4. 4
    Melatonin promotes neuroblastoma cell differentiation by activating hyaluronan synthase 3‐induced mitophagy

    Melatonin promotes neuroblastoma cell differentiation by activating hyaluronan synthase 3‐induced mitophagy by Wen‐Jui Lee, Li‐Ching Chen, Juo‐Han Lin, Tzu‐Chun Cheng, Ching‐Chuan Kuo, Chih‐Hsiung Wu, Hui‐Wen Chang, Shih‐Hsin Tu, Yuan‐Soon Ho

    Published 2019-08-01
    Get full text
    Article
  5. 5
    MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma.

    MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma. by Hsuan-Yu Peng, Yun-Ching Cheng, Yuan-Ming Hsu, Guan-Hsun Wu, Ching-Chuan Kuo, Jing-Ping Liou, Jang-Yang Chang, Shiow-Lian Catherine Jin, Shine-Gwo Shiah

    Published 2016-01-01
    Get full text
    Article
  6. 6
    Surface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target.

    Surface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target. by Kuan-Chung Hsiao, Neng-Yao Shih, Hsun-Lang Fang, Tze-Sing Huang, Ching-Chuan Kuo, Pei-Yi Chu, Yi-Mei Hung, Shao-Wen Chou, Yi-Yuan Yang, Gee-Chen Chang, Ko-Jiunn Liu

    Published 2013-01-01
    Get full text
    Article
  7. 7
    Type-3 Hyaluronan Synthase Attenuates Tumor Cells Invasion in Human Mammary Parenchymal Tissues

    Type-3 Hyaluronan Synthase Attenuates Tumor Cells Invasion in Human Mammary Parenchymal Tissues by Wen-Jui Lee, Shih-Hsin Tu, Tzu-Chun Cheng, Juo-Han Lin, Ming-Thau Sheu, Ching-Chuan Kuo, Chun A. Changou, Chih-Hsiung Wu, Hui-Wen Chang, Hang-Lung Chang, Li-Ching Chen, Yuan-Soon Ho

    Published 2021-10-01
    Get full text
    Article
  8. 8
    Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death

    Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death by Chih-Peng Lin, Shu-Hui Wu, Tzu-Yin Lin, Chia-Hui Chu, Leu-Wei Lo, Ching-Chuan Kuo, Jang-Yang Chang, Szu-Chun Hsu, Bor-Sheng Ko, Ming Yao, Jong-Kai Hsiao, Shih-Wei Wang, Dong-Ming Huang

    Published 2023-11-01
    Get full text
    Article
  9. 9
    Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models

    Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models by Ya-Chu Tang, Jing-Jim Ou, Shu-Ching Hsu, Chih-Hsiang Huang, Li-Mei Lin, Hsin-Huei Chang, Yi-Hsin Wang, Zih-Ting Huang, Manwu Sun, Ko-Jiunn Liu, Yi-Mei Hung, Chi-Yun Lai, Chuan Shih, Chiung-Tong Chen, Jang-Yang Chang, Hsing-Pang Hsieh, Weir-Torn Jiaang, Ching-Chuan Kuo

    Published 2025-01-01
    Get full text
    Article

Search Tools: